Drugs / DTPa-IPV-HepB-Hib
DTPa-IPV-HepB-Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00667602 Background | Mar 2008 → Jul 2009 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-IPV-HepB-Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00667602 ↗ |
| Known as | Combined Diphtheria-Tetanus-acellular Pertussis, Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae type b | “One 0.5mL dose of Combined Diphtheria-Tetanus-acellular Pertussis, Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae type b (DTPa-IPV-HepB-Hib) vaccine was...” NCT00667602 ↗ |
| Modality | Vaccine | “(DTPa-IPV-HepB-Hib) vaccine” NCT00667602 ↗ |
| Route | Intramuscular | “administered by intramuscular injection” NCT00667602 ↗ |